Lexaria Bioscience LEXX
NASDAQ LEXX
$2.82 +0.17 (+6.42%)
At close: Oct 21, 2026 · 4:00 PM EDT

Lexaria Bioscience (LEXX) Tax Provisions (2025 - 2026)

Updated

Lexaria Bioscience (LEXX) reported Tax Provisions of $14.00 for fiscal Q3 2026 (quarter ended May 31, 2026), down 99.5% from the prior quarter.

Analysis

Lexaria Bioscience (LEXX) Tax Provisions (2025 - 2026) Analysis & Trends

Over the twelve months ended May 31, 2026, Lexaria Bioscience's Tax Provisions came in at $4,403.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 2.15 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 1.21 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 662.00 Mn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 654.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 1.01 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 291.00 Mn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 393.00 Mn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 242.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -407.00 Mn
10 Lexaria Bioscience 2.58 Mn -12.67 Mn - 14.00
Historic Data

Historic Data

Download Data
DateValue
May 31, 2026 14.00
Feb 28, 2026 2,598.00
Nov 30, 2025 1,791.00
API Access

Lexaria Bioscience Tax Provisions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=tax-provisions&ticker=LEXX&period=max&api_key=YOUR_API_KEY